NSE · INDOUS
Indo Us Biotech Limited (INDOUS) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,765
of 5,047 stocks
▼ 161W▼ 661M
Peak #2,596 · 02 Oct 2026
Operating in Healthcare, Indo Us Biotech Limited trades at an undemanding earnings multiple, remains firmly promoter-controlled, with promoters holding 68%, and is growing revenue modestly.
Market Cap
132.74 Cr
P/E Ratio
10.12
P/B Ratio
1.43
ROE
14.18%
ROCE
17.27%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 15.05 Cr | 32.99 Cr | 26.02 Cr | 22.80 Cr |
| Net Profit | -3.67 Cr | 3.04 Cr | 1.97 Cr | 3.00 Cr |
| EPS | -1.83 | 1.51 | 0.98 | 1.49 |
| Operating Profit | -2.83 Cr | 3.82 Cr | 2.98 Cr | 3.93 Cr |
Shareholding pattern
Promoter
68.29%
Public
31.71%
PUBLIC BREAKDOWN
FII
0.01%
Individuals
24.67%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 03 Dec 2024 | Dividend | Interim Dividend - Rs 0.25 Per Share |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.